İçeriğe geç

Onkoloji (Çocuk)

Kişiye Özel/Modifiye Kemoterapi (Doz Ayarlama veya Geciktirme)

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (yeni pencere açar)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Kaynak‎: N Engl J Med 1998;338(8):499-505.

İndeks‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (yeni pencere açar)

Childhood cancer and the Jehovah's Witness faith. (yeni pencere açar)

Frankel LS, Damme CJ, Eys JV.

Kaynak‎: Pediatrics 1977;60(6):916-21.

İndeks‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (yeni pencere açar)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (yeni pencere açar)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Kaynak‎: J Clin Oncol 2004;22(24):4888-92.

İndeks‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (yeni pencere açar)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (yeni pencere açar)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Kaynak‎: JAMA Oncol 2022;8(1):79-87. 

İndeks‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (yeni pencere açar)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (yeni pencere açar)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Kaynak‎: Haematologica 2000;85(11):1221-2.

İndeks‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (yeni pencere açar)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (yeni pencere açar)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Kaynak‎: Bone Marrow Transplant 2016;51(7):1002-3.

İndeks‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (yeni pencere açar)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (yeni pencere açar)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Kaynak‎: Bone Marrow Transplant 2003;32(4):433-6.

İndeks‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (yeni pencere açar)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (yeni pencere açar)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Kaynak‎: Bone Marrow Transplant 2005;36(8):715-20.

İndeks‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (yeni pencere açar)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (yeni pencere açar)

Zwaan CM, Kaspers GJ

Kaynak‎: Br J Haematol 2004;127(3):264-79.

İndeks‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (yeni pencere açar)